Table 4.
Incidence of ED across various sample characteristics
| ED 23 (6.6%) | |
|---|---|
| Gender | |
| Female | 8 (4.3%) |
| Male | 15 (7.0%) |
| χ2=1.350, P=0.245 | |
| Age category | |
| Preschooler (<6 years) | 20 (6.9%) |
| School (≥6 years) | 3 (2.6%) |
| χ2=2.816, P=0.093 | |
| BMI categories | |
| Underweight/normal weight | 18 (5.5%) |
| Overweight/obese | 5 (6.5%) |
| χ2=0.105, P=0.746 | |
| Surgery category | |
| Type 1 | 18 (5.6%) |
| Type 2 | 5 (6.4%) |
| χ2=0.085, P=0.770 | |
| Type of anesthesia | |
| Local anesthesia | 17 (6.2%) |
| General only | 6 (4.9%) |
| χ2=0.274, P=0.601 | |
| Intraop Precedex | |
| No | 21 (10.1%) |
| Yes | 2 (1.1%) |
| χ2=14.531, P<0.001* | |
| Intraop paracetamol/NSAID | |
| No | 4 (11.1%) |
| Yes | 19 (5.3%) |
| F-exact, P=0.149 | |
| Intraop fentanyl | |
| No | 2 (6.7%) |
| Yes | 21 (5.8%) |
| F-exact, P=0.846 | |
| Intraop Tramal/morphine | |
| No | 23 (6.6%) |
| Yes | 0 (0.0%) |
| F-exact, P=0.228 |
ED: Emergence delirium; BMI: Body mass index; NSAID: Nonsteroidal anti-inflammatory drug. χ2: Pearson’s Chi-square; F: Fisher exact, P: p-value. *Statistically significant at <0.05